How the ground-breaking research of Professor Vincenzo Cerullo and his group at the ImmunoViroTherapy Lab at Helsinki University led to the founding of the spin-out company Valo Therapeutics (ValoTx), setting out to make cancer immunotherapy more effective and accessible to patients.
Authors
European Innovation Council and SMEs Executive Agency, European Commission
- Catalogue number
- EA-02-23-177-EN-N
- Citation
- European Commission, European Innovation Council and SMEs Executive Agency, European IP Helpdesk case study – Developing personalised immunotherapies for cancer , Publications Office of the European Union, 2023, https://data.europa.eu/doi/10.2826/67018
- DOI
- https://data.europa.eu/doi/10.2826/67018
- ISBN
- 978-92-9469-632-8
- Pages
- 17
- Published in
- Belgium
- Themes
- Medical and biological research , Patents – Protection of intellectual property
